Transdel Pharmaceuticals to Present at Cowen and Company's 28th Annual Health Care ... ( LA JOLLA Calif. March 18 /- Trans...)

Transdel Pharmaceuticals to Present at Cowen and Company's 28th Annual Health Care Conference

Date:3/18/2008

LA JOLLA, Calif., March 18 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically administered medications, today announced that Dr. Juliet Singh, President and Chief Executive Officer, will present at Cowen and Company's 28th Annual Health Care Conference on Thursday, March 20, 2008 at 10:15 a.m. Eastern Time at The Marriott Copley Place in Boston, MA.

Dr. Singh will discuss the Company's business developments to date including the recent submission of the Phase 3 clinical study of Ketotransdel(TM) to the FDA.

Interested parties can access a live audio webcast and accompanying slide presentation via the Internet by visiting the Investor Relations section of the Company's Web site at http://www.transdelpharma.com. An archived presentation will be available on the Web site for 30 days.

About Transdel Pharmaceuticals, Inc.

Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP) is a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically delivered medications. The Company's lead topical drug, Ketotransdel(TM), utilizes the Company's innovative patented proprietary Transdel(TM) cream formulation technology to facilitate the passage of ketoprofen, an NSAID, through the skin barrier to reach targeted underlying tissue where the drug exerts its prolonged localized anti-inflammatory and analgesic effect. The Company is also investigating other drug candidates and treatments for transdermal delivery using the patented Transdel(TM) platform technology for products in pain management and other therapeutic areas.

Safe Harbor Statement

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertain
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
2. Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
3. Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March
4. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
5. ISTA Pharmaceuticals to Present at the Cowen & Company 28th Annual Health Care Conference
6. SGX Pharmaceuticals Announces Fourth Quarter and Full Year Financial Results
7. Onyx Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
8. Idenix Pharmaceuticals to Present at the Eleventh Annual Lehman Brothers Global Healthcare Conference
9. Drinking Water Association Discusses Pharmaceuticals in Water
10. Genesis Pharmaceuticals Changes Auditors
11. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials

Post Your Comments:

(Date:5/25/2013)... Many viruses and parasites that affect both dogs and ... illness than can result in liver or kidney failure ... a veterinarian. These germs could be found ... Dr. Susan Nelson, a clinical associate professor at Kansas ... diseases can be fatal, even with treatment," she said ...

(Date:5/25/2013)... TX (PRWEB) May 25, 2013 Studies ... those who are carrying excessive weight and their inability ... for many, simply losing weight can naturally relieve many ... found that improvement in sleep quality was significantly associated ... six month study dated November 6th, 2012, ...

(Date:5/25/2013)... York, New York (PRWEB) May 25, 2013 ... who allegedly suffered serious, life-threatening episodes of internal bleeding while ... litigation underway in U.S. District Court, Southern District of Illinois, ... the Court’s website, 818 Pradaxa side effect claims had ... 2013. That’s up from 705 claims reported by the ...

(Date:5/25/2013)... (PRWEB) May 25, 2013 According ... Emergency Management Market, 2013–2018", published by MarketsandMarkets is ... a CARC of 5.54% which analyzes and studies ... North America, Europe, Asia, and Rest of the ... Market Data Tables , 87 Figures ...

(Date:5/25/2013)... 25, 2013 Acuity Games ’ innovative ... version of Word Hunt is available today, expanding ... Edge Match, Flash 2, Sudoku and Matchematics will roll out ... gameplay and revolutionary lifetime brain fitness measurement have been re-optimized ... “100 years of brain fitness measurement in your pocket. ...

Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2 Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2 Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3 Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4 Health News:Acuity Games Apps Come to the iPhone 2

[0] Hidden Dangers Dog Dog Parks [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep [0] Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports [0] Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets [0] Acuity Games Apps Come to the iPhone

... President,and CEO of America,s Health Insurance Plans, today ... ), "Today,s announcement presents an opportunity to ... rising health care costs in America., "At ... soar above inflation,every year, health insurance plans, tools ...

... Parenthood TV Ad For Containing,Inappropriate, Content While Original ... 13 "It is outrageous that,YouTube would black-out ... sex video while it continues to carry the ... of American Life League., The "inappropriate nature" ...

... replicated in larger study, experts caution , , WEDNESDAY, Feb. ... combat cancer that is now being used to treat ... also work against a common form of multiple sclerosis. ... issue of the New England Journal of Medicine ...

... SEGUNDO, Calif., Feb. 13 DaVita Inc.,(NYSE: DVA ... ended December,31, 2007. Net income for the three months ... share, as compared to $74.1 million, or $0.70 per,share, ... http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ), Net income for the year ended ...

... Eight outstanding cancer care providers from a variety of ... 2008 American Cancer Society Lane W. Adams Quality of ... The Lane W. Adams Quality of Life Award recognizes ... and consistent excellence in providing compassionate, skilled care, and ...

... COEUR D,ALENE, Idaho, Feb. 13 NightHawk,Radiology Holdings, Inc. (Nasdaq: ... groups across the United States, today announced,financial results for its ... 2007 Highlights, -- Full year revenues grew 65% to ... the full-year 2006. Organic revenue grew $21.4 million, or 23% ...

AHIP Statement on New York Attorney General's Announcement ICYMI: YouTube Censors American Life League Cancer Drug Works Against MS in Early Trial DaVita 4th Quarter 2007 Results American Cancer Society honors exemplary cancer caregivers NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance

(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... Annual Healthcare Conference on Thursday, May 30, 2013, at ... beginning at 9:20 a.m. Eastern Daylight Time. Arvind ... will present at the conference. Live audio of the presentation ... www.amgen.com , under Investors. A replay of the webcast ...

(Date:5/23/2013)... , May 23, 2013 A recently published ... Houston, Texas , demonstrates that 3D ... increasing cancer detection. The study, "Implementation ... Observational Study," was led by Stephen L. ... issue of the American Journal of Roentgenology ...

(Date:5/23/2013)... May 23, 2013 Anthem Blue Cross patients ... have required them to obtain their medications by mail ... and Whatley Kallas LLC. The lawsuit, ... that Blue Cross,s mandatory mail order program announced late ... and privacy. "This settlement brings to a ...

Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2 First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3 Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2 Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3

[0] Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference [0] First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams [0] Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog

... November 4, 2010 ... ... --> ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r in ...

... (OTCQB: CGCP), a leading developer of surgical products used ... reported financial results for its third quarter and first ... for the third quarter of 2010 was $2,764,000, a ... $2,134,000. Gross margin was 84% for the quarter, two ...

Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development Cardiogenesis Reports Third Quarter 2010 Results

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

Medicine Products:

Isopropanol (Includes Acetone)Isofedrol Isoenzymes, Amylase Islet Cell Antigen (ICA) 512